Mecamylamine-precipitated nicotine-withdrawal aversion in Lewis and Fischer 344 inbred rat strains.
Many studies have indicated that Lewis and Fischer 344 inbred rat strains show marked differences in behavioral responses to abused drugs. In the present study, we sought to determine whether these two strains of rats show different responses in mecamylamine-precipitated nicotine-withdrawal aversion using the conditioned place preference paradigm. Rats were treated subcutaneously with 10 mg/kg/day nicotine for 7 days using an osmotic minipump. After chronic nicotine infusion, the nicotinic receptor antagonist mecamylamine produced a significant place aversion in Lewis, but not in Fischer 344 rats. These results suggest that mecamylamine-precipitated nicotine-withdrawal aversion is strongly regulated by genetic factors.
Suzuki
T
T
Department of Toxicology, School of Pharmacy, Hoshi University, Tokyo, Japan. suzuki@hoshi.ac.jp
Ise
Y
Y
Maeda
J
J
Misawa
M
M
D000818:Animals; D005731:Ganglionic Stimulants / Q000494:pharmacology*; D008297:Male; D008464:Mecamylamine / Q000494:pharmacology*; D009538:Nicotine / Q000009:adverse effects* / Q000235:genetics / Q000494:pharmacology; D018733:Nicotinic Antagonists / Q000494:pharmacology*; D051381:Rats; D011916:Rats, Inbred F344 / Q000235:genetics*; D011917:Rats, Inbred Lew / Q000235:genetics*; D013045:Species Specificity; D013375:Substance Withdrawal Syndrome / Q000235:genetics / Q000517:prevention & control*
D005731:Ganglionic Stimulants; D018733:Nicotinic Antagonists; D008464:Mecamylamine; D009538:Nicotine